USPH
NYSE · Health Care
U.S. Physical Therapy Inc
$85.58
+1.51 (+1.80%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 677.59M | 612.15M | 713.83M | 680.46M | 584.51M |
| Net Income | 31.72M | 25.79M | 85.85M | 84.11M | 68.29M |
| EPS | — | — | — | — | — |
| Profit Margin | 4.7% | 4.5% | 12.0% | 12.4% | 11.7% |
| Rev Growth | +10.7% | +10.7% | -9.1% | +22.6% | +15.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 155.47M | 155.47M | 93.99M | 109.70M | 120.61M |
| Total Equity | 495.12M | 495.12M | 892.43M | 934.36M | 966.56M |
| D/E Ratio | 0.31 | 0.31 | 0.11 | 0.12 | 0.12 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 82.35M | 70.68M | 109.59M | 108.87M | 97.49M |
| Free Cash Flow | — | — | 55.84M | 45.81M | 45.13M |